Death Clinical Trial
— BEAMOfficial title:
Beijing Disability Risk and Ageing Monitoring Study
NCT number | NCT06394817 |
Other study ID # | 2022234 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | February 20, 2023 |
Est. completion date | May 2063 |
This is a community-based prospective cohort study in Beijing, China. The study has been initialized in 2023 and enrolled older residents. This study aims to develop disability risk assessment standards and an early warning model for older adults.
Status | Recruiting |
Enrollment | 2000 |
Est. completion date | May 2063 |
Est. primary completion date | May 2063 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years and older |
Eligibility | Inclusion Criteria: - Aged 60 years or older - Lived in the community for more than 1 year - Signed the informed consent form Exclusion Criteria: - Cannot complete the survey |
Country | Name | City | State |
---|---|---|---|
China | Xuanwu Hospital, Capital Medical University | Beijing |
Lead Sponsor | Collaborator |
---|---|
Xuanwu Hospital, Beijing |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The prevalence and incidence of functional disability using a population-based survey | Functional disability was measured by Activities of Daily Living, cognitive function (Mini-Mental State Examination) and movement disorder(Short Physical Performance Battery) collected by questionnaires.The minimum value of the Activities of Daily Living is 0, and the maximum value is 100, the higher the score, the better the outcome.The minimum value of the Mini-Mental State Examination is 0, and the maximum value is 30, the higher the score, the better the outcome.The minimum value of the Short Physical Performance Battery is 0, and the maximum value is 12, the higher the score, the better the outcome. | An average of 1 to 2 years | |
Primary | The prevalence and incidence of mild cognitive impairment using a population-based survey | Mild cognitive impairment was measured using Mini-Mental State Examination collected by questionnaire.The minimum value of the Mini-Mental State Examination is 0, and the maximum value is 30, the higher the score, the better the outcome. | An average of 1 to 2 years | |
Primary | The prevalence and incidence of dementia using a population-based survey | Dementia was determined by diagnosis of hospitalization or diagnosis of death or Clinical Dementia Rating scale. The minimum value of the Clinical Dementia Rating is 0, and the maximum value is 3, the higher the score, the worse the outcome. | An average of 1 to 2 years | |
Primary | The conversion rate of normal to mild cognitive impairment | Percentage of enrolled population that convert from normal to mild cognitive impairment | An average of 1 to 2 years | |
Primary | The conversion rate of mild cognitive impairment to dementia | Percentage of enrolled population that convert from mild cognitive impairment to dementia | An average of 1 to 2 years | |
Primary | The genetic and environmental factors for mild cognitive impairment and dementia at genomic and expression levels | Discover risk factors including genetic susceptibility loci (APOE genes and other risk genes) using gene sequencing, cardiovascular risk factors (blood glucose, cholesterol, homocysteine) using laboratory tests, and unhealthy lifestyle using questionnaire. | An average of 1 to 2 years | |
Primary | The biomarkers for normal, mild cognitive impairment, and dementia diagnosis | Humoral biomarkers are included Aß42, Aß40, phosphated tau and total tau in plasma, cerebrospinal fluid, saliva, and urine. Imaging biomarkers are included cerebral volume, glucose metabolism, amyloid and tau deposition of whole brain or hippocampus. | An average of 1 to 2 years | |
Primary | The prevalence and incidence of movement disorder using a population-based survey | Movement disorder was measured using Short Physical Performance Battery collected by questionnaire.The minimum value of the Short Physical Performance Battery is 0, and the maximum value is 12, the higher the score, the better the outcome. | An average of 1 to 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Recruiting |
NCT02552706 -
The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis
|
N/A | |
Completed |
NCT01569178 -
BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction
|
Phase 3 | |
Recruiting |
NCT01193751 -
Apgar-Score in Asphyxiated Infants Under Resuscitation
|
N/A | |
Active, not recruiting |
NCT01597453 -
NOR-SYS: The Norwegian Stroke in the Young Study
|
N/A | |
Completed |
NCT00399503 -
Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a Heart Attack
|
N/A | |
Completed |
NCT05128799 -
Effect of the 3 Wishes Program on Bereaved Families' End-of-Life Care Perceptions
|
||
Completed |
NCT00340015 -
A Prospective Study of Diet and Cancer in Members of the American Association of Retired Persons
|
||
Active, not recruiting |
NCT01618123 -
Association of Endothelial Function and Clinical Outcomes in Subjects Admitted to Chest Pain Unit
|
||
Completed |
NCT01008241 -
South Florida Residents Knowledge and Opinions on End-of-Life Issues
|
||
Completed |
NCT00225394 -
Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients
|
Phase 4 | |
Terminated |
NCT05518474 -
Self-proning and Repositioning in COVID-19 Outpatients at Risk of Complicated Illness
|
N/A | |
Completed |
NCT02533128 -
Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery
|
N/A | |
Recruiting |
NCT05199025 -
Biomarkers in Perioperative Management
|
||
Not yet recruiting |
NCT06371677 -
Polish Nationwide Register of Hospitalized Patients in Cardiac Intensive Care Units
|
||
Completed |
NCT04709120 -
Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection
|
||
Enrolling by invitation |
NCT05374291 -
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
|
Phase 3 | |
Recruiting |
NCT01792739 -
Lactobacillus Preparation on the Incidence of Diarrhea
|
Phase 4 | |
Completed |
NCT00753428 -
Community-based Evaluation of a Pilot PMTCT Project in Kafue District
|
||
Completed |
NCT00495690 -
Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease
|
Phase 3 |